The Race Is On. When Will Korea Have Its Own Approved Gene Therapy?

While global pharma firms are rolling out advanced gene and cell therapies, as well as aggressively making R&D investments in the space to grab the leading position in the burgeoning market, South Korea is still seen as lagging behind in the development of these innovative modalities such as CAR-T cell therapies.

According to the recent Cell, Gene & RNA Therapy Landscape report from Informa Pharma Intelligence and the American Society of Gene + Cell Therapy, a total of 89 gene, cell and RNA therapies had been approved in the global market as of the fourth quarter of 2021